Contact:
Mary D’Rozario
Director of Communications
Society for Clinical Research Sites
919.890.5513
mary.drozario@myscrs.org
FOR IMMEDIATE RELEASE
Ellicott City, MD, July 6, 2017 — The Society for Clinical Research Sites (SCRS) announced today that Novo Nordisk is a new Global Impact Partner (GIP). Novo Nordisk is a global health care company providing leadership and innovation in the care of diabetes and other chronic diseases. As a GIP, Novo Nordisk will serve on the SCRS Global Impact Board, working with the Leadership Council to set and pursue strategic initiatives.
“Novo Nordisk’s commitment to sites was recognized when they were the sponsor winner of the 2016 SCRS Eagle Award,” said SCRS president, Christine Pierre. “We are excited Novo Nordisk is showing their support of the sites through collaboration with SCRS as a GIP.”
“Building strong relationships with our clinical research sites is a driving factor in our mission to discover and develop better biological medicines,” said Kate Owen, Vice President, Clinical Trial Management. “Joining SCRS as a Global Impact Partner is an exciting opportunity to partner with industry leaders to collaborate on research practices that will ultimately drive change to improve patient lives.”
###
About Novo Nordisk Inc.
Novo Nordisk is a global health care company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity. With U.S. headquarters in Plainsboro, N.J., Novo Nordisk Inc. has nearly 5,000 employees in the United States. For more information, visit novonordisk.us or follow us on Twitter: @novonordiskus.
About SCRS
SCRS is a global trade organization founded in 2012 which represents almost 9,000 research sites in over 45 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Our Voice. Our Community. Your Success. Join the community and collaborate with the global experts in site sustainability. Visit MySCRS.org.